14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of 0512.HK
Powered by GPT-4o
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

China Grand Pharmaceutical and stock upgraded to Hold/Accumulate.
(Updated on Jun 18, 2024)

Hold candidate since Jun 18, 2024 PDF

The China Grand Pharmaceutical and stock price gained 2.10% on the last trading day (Tuesday, 18th Jun 2024), rising from HK$4.76 to HK$4.86. During the last trading day the stock fluctuated 3.83% from a day low at HK$4.70 to a day high of HK$4.88. The price has fallen in 5 of the last 10 days and is down by -3.95% for this period. Volume fell on the last day by -286 thousand shares and in total, 3 million shares were bought and sold for approximately HK$16.61 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the lower part of a wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at HK$4.78 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 32.40% during the next 3 months and, with a 90% probability hold a price between HK$6.33 and HK$7.10 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

0512.HK Signals & Forecast

The China Grand Pharmaceutical and stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at HK$4.83 and HK$4.83. A breakdown below any of these levels will issue sell signals. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Tuesday, June 04, 2024, and so far it has fallen -5.81%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for China Grand Pharmaceutical and stock

China Grand Pharmaceutical and finds support from accumulated volume at HK$4.82 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved HK$0.180 (3.83%) between high and low. For the last week, the stock has had daily average volatility of 3.63%.

Our recommended stop-loss: HK$4.59 (-5.54%) (This stock has low daily movements and this gives low risk. There is a sell signal from a pivot top found 49 days ago.)

Trading Expectations (0512.HK) For The Upcoming Trading Day Of Wednesday 19th

For the upcoming trading day on Wednesday, 19th we expect China Grand Pharmaceutical and Healthcare Holdings Limited to open at HK$4.81, and during the day (based on 14 day Average True Range), to move between HK$4.67 and HK$5.05, which gives a possible trading interval of +/-HK$0.186 (+/-3.83%) up or down from last closing price. If China Grand Pharmaceutical and Healthcare Holdings Limited takes out the full calculated possible swing range there will be an estimated 7.66% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at HK$4.82 (0.82%) than the resistance at HK$4.95 (1.85%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is China Grand Pharmaceutical and Healthcare Holdings Limited stock A Buy?

China Grand Pharmaceutical and holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.

Current score: 0.214 Hold/Accumulate Upgraded

Predicted Opening Price for China Grand Pharmaceutical and Healthcare Holdings Limited of Wednesday, June 19, 2024

Fair opening price June 19, 2024 Current price
HK$4.81 ( 0.96%) HK$4.86

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for 0512.HK

Fibonacci Support & Resistance Levels

Level Price
R3 4.99 2.74%
R2 4.92 1.33%
R1 4.88 0.455%
Price 4.86
S1 4.74 -2.38%
S2 4.70 -3.25%
S3 4.63 -4.66%

Accumulated Volume Support & Resistance Levels

Level Price
R3 4.98 2.47%
R2 4.97 2.26%
R1 4.95 1.85%
Price 4.86
S1 4.82 -0.82%
S2 4.75 -2.26%
S3 3.85 -20.78%

0512 Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Jun 07, 2024 Jun 07, 2024 Jun 27, 2024 HK$0.260 5.38%
2 Jun 06, 2024 Jun 06, 2024 Jun 27, 2024 HK$0.260 5.38%
3 Jun 09, 2023 Jun 09, 2023 Jun 09, 2023 HK$0.140 3.05%
4 Jun 06, 2022 Jun 06, 2022 Jun 06, 2022 HK$0.110 2.69%
5 Jun 08, 2021 Jun 08, 2021 Jun 08, 2021 HK$0.110 1.42%

FAQ

What is the symbol for China Grand Pharmaceutical and Healthcare Holdings Limited Stock and on which exchange is it traded?
The symbol for China Grand Pharmaceutical and Healthcare Holdings Limited is 0512.HK and it is traded on the HKEX (Hong Kong Stock Exchange).

Should I buy or sell China Grand Pharmaceutical and Healthcare Holdings Limited Stock?
China Grand Pharmaceutical and holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.

How to buy China Grand Pharmaceutical and Healthcare Holdings Limited Stock?
China Grand Pharmaceutical and Healthcare Holdings Limited Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy China Grand Pharmaceutical and Healthcare Holdings Limited Stock.

What's the current price of China Grand Pharmaceutical and Healthcare Holdings Limited Stock?
As of the end of day on the Jun 18, 2024, the price of an China Grand Pharmaceutical and Healthcare Holdings Limited (0512.HK) share was HK$4.86.

What is the 52-week high and low for China Grand Pharmaceutical and Healthcare Holdings Limited Stock?
The 52-week high for China Grand Pharmaceutical and Healthcare Holdings Limited Stock is HK$5.31 and the 52-week low is HK$3.17.

What is the market capitalization of China Grand Pharmaceutical and Healthcare Holdings Limited Stock?
As of the Jun 18, 2024, the market capitalization of China Grand Pharmaceutical and Healthcare Holdings Limited is 17.019B.
Click to get the best stock tips daily for free!

About China Grand Pharmaceutical and Healthcare Holdings Limited

China Grand Pharmaceutical and Healthcare Holdings Limited Grand Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials. The company offers pharmaceutical preparations, including cerebro-cardiovascular emergency medicines; respiratory, ophthalmic, anti-infection, and ENT medicines; oncology medicines; and rare dise... 0512.HK Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT